Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data

Background Liver injury has been documented independently in novel coronavirus disease 2019 (COVID-19) patients and patients treated with lopinavir-ritonavir. Objective to investigate the drug-induced liver injury associated with lopinavir-ritonavir among the patients with COVID-19. Methods We condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Huilin, Zhou, Liyuan, Li, Xiaotong, Kinlaw, Alan C., Yang, Jeff Y., Moon, Andrew M., Barnes, Edward L., Wang, Tiansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323539/
https://www.ncbi.nlm.nih.gov/pubmed/34328585
http://dx.doi.org/10.1007/s11096-021-01311-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323539/
https://www.ncbi.nlm.nih.gov/pubmed/34328585
http://dx.doi.org/10.1007/s11096-021-01311-5

Ejemplares similares